Insights

Innovative Delivery Platform NanoVation's proprietary lcLNP™ technology offers a unique ability to target tissues outside the liver, presenting a significant opportunity to partner with pharmaceutical companies seeking advanced solutions for extrahepatic nucleic acid delivery.

Strategic Pharma Partnerships Recent collaborations with industry leaders like Novo Nordisk highlight NanoVation's capacity to secure multi-year alliances, indicating strong interest from top biotech firms in leveraging their novel genetic medicine platforms.

Award-Winning Recognition Receiving the Deal of the Year at the Life Sciences BC Awards underscores NanoVation's innovative approach, enhancing its credibility and attractiveness as a partner for investment and collaborative development projects.

Growing Industry Footprint With funding rounds led by notable venture capital firms and expanding board leadership, NanoVation is positioned for accelerated growth, creating opportunities for investors and strategic partners in biotechnology innovation.

Market Expansion Potential Targeting rare and cardiometabolic diseases with advanced gene delivery, NanoVation's technology aligns with emerging market trends, offering sales opportunities in high-growth therapeutic areas and unmet medical needs.

NanoVation Therapeutics Tech Stack

NanoVation Therapeutics uses 8 technology products and services including Squarespace Commerce, 15Five, JSON-LD, and more. Explore NanoVation Therapeutics's tech stack below.

  • Squarespace Commerce
    E-commerce
  • 15Five
    Human Resource Management System
  • JSON-LD
    Javascript Frameworks
  • Ubuntu
    Operating Systems
  • Cloudways
    Platform As A Service
  • Cloudflare Bot Management
    Security
  • Google Analytics
    Web Analytics
  • Magnific Popup
    Web Tools And Plugins

Media & News

NanoVation Therapeutics's Email Address Formats

NanoVation Therapeutics uses at least 1 format(s):
NanoVation Therapeutics Email FormatsExamplePercentage
F.Last@nanovationtx.comJ.Doe@nanovationtx.com
100%

Frequently Asked Questions

Where is NanoVation Therapeutics's headquarters located?

Minus sign iconPlus sign icon
NanoVation Therapeutics's main headquarters is located at 2665 East Malecón Vancouver, British Columbia v6t 1z4 Canada. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is NanoVation Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
NanoVation Therapeutics's official website is nanovationtx.com and has social profiles on LinkedInCrunchbase.

What is NanoVation Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
NanoVation Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NanoVation Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2026, NanoVation Therapeutics has approximately 46 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer And Co-Founder: J. K.Vice President Operations: D. B.Vice President Finance: T. C.. Explore NanoVation Therapeutics's employee directory with LeadIQ.

What industry does NanoVation Therapeutics belong to?

Minus sign iconPlus sign icon
NanoVation Therapeutics operates in the Biotechnology Research industry.

What technology does NanoVation Therapeutics use?

Minus sign iconPlus sign icon
NanoVation Therapeutics's tech stack includes Squarespace Commerce15FiveJSON-LDUbuntuCloudwaysCloudflare Bot ManagementGoogle AnalyticsMagnific Popup.

What is NanoVation Therapeutics's email format?

Minus sign iconPlus sign icon
NanoVation Therapeutics's email format typically follows the pattern of F.Last@nanovationtx.com. Find more NanoVation Therapeutics email formats with LeadIQ.

When was NanoVation Therapeutics founded?

Minus sign iconPlus sign icon
NanoVation Therapeutics was founded in 2020.

NanoVation Therapeutics

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery).

NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery to extrahepatic cell types and has demonstrated an improved therapeutic index in preclinical studies.

NanoVation partners with leading pharmaceutical and biotech companies develop genetic medicines for previously untreatable diseases.
NVTx is delivering tomorrow's genetic medicines, today.

For more information, please visit nanovationtx.com.

Section iconCompany Overview

Headquarters
2665 East Malecón Vancouver, British Columbia v6t 1z4 Canada
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    NanoVation Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    NanoVation Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.